Analysts from Forbes Advisor suggest that while valuations have fallen roughly 90% over the past five years, current entry points may offer improved risk/reward profiles for long-term investors.
: As of April 23, 2026, medical cannabis is no longer subject to Section 280E of the Internal Revenue Code. This allows companies to deduct normal business expenses, potentially unlocking $1.6B to $2.2B in annual after-tax cash flow for the industry. weed stocks to buy
AdvisorShares Pure US Cannabis ETF (MSOS) or YOLO for broader exposure Analysts from Forbes Advisor suggest that while valuations
: Massive U.S. footprint combined with an aggressive expansion into Germany and the UK. weed stocks to buy